다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

SNPX

Synaptogenix (SNPX)

Synaptogenix Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNPX

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNPX	Synaptogenix Inc
2024/05/07	22:00	PR Newswire (US)	Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery	NASDAQ:SNPX	Synaptogenix Inc
2024/04/24	22:15	PR Newswire (US)	Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing	NASDAQ:SNPX	Synaptogenix Inc
2024/04/09	22:15	PR Newswire (US)	Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics	NASDAQ:SNPX	Synaptogenix Inc
2024/04/03	21:00	PR Newswire (US)	Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing	NASDAQ:SNPX	Synaptogenix Inc
2024/02/07	00:16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SNPX	Synaptogenix Inc
2023/12/22	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/12/19	23:00	PR Newswire (US)	Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders	NASDAQ:SNPX	Synaptogenix Inc
2023/12/06	23:00	PR Newswire (US)	Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's	NASDAQ:SNPX	Synaptogenix Inc
2023/11/15	07:05	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SNPX	Synaptogenix Inc
2023/11/14	07:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2023/11/07	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/11/04	06:00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2023/11/02	22:00	PR Newswire (US)	Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology	NASDAQ:SNPX	Synaptogenix Inc
2023/09/26	22:00	PR Newswire (US)	Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease	NASDAQ:SNPX	Synaptogenix Inc
2023/09/23	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/09/07	22:00	PR Newswire (US)	Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study	NASDAQ:SNPX	Synaptogenix Inc
2023/08/15	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNPX	Synaptogenix Inc
2023/07/19	22:00	PR Newswire (US)	Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis	NASDAQ:SNPX	Synaptogenix Inc
2023/07/19	21:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/07/13	22:00	PR Newswire (US)	Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience	NASDAQ:SNPX	Synaptogenix Inc
2023/06/23	06:15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNPX	Synaptogenix Inc
2023/05/16	05:51	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/29	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/15	06:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/01	05:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/01	05:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/01	05:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNPX	Synaptogenix Inc
2023/04/01	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNPX	Synaptogenix Inc
2023/03/22	06:24	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNPX	Synaptogenix Inc

검색 관련기사 보기:NASDAQ:SNPX

1 2 3 4 다음 >>

ETFS 1x Daily Short WTI ...

Source SBIO iNav

NLBNPIT21AD3 20991231 4....

DIIF25F29 - 01/2025

Societe Generale Effekten

Cybeats Technologies

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관